L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide

L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide is an experimental small molecule compound classified as a dipeptide derivative. It is primarily used in biomedical research and drug development as an inhibitor of nitric oxide synthase enzymes. The compound acts by inhibiting the production of nitric oxide (NO), a key signaling molecule involved in various physiological processes including neurotransmission and vascular regulation. Its main mechanism involves competitive inhibition at the active site of nitric oxide synthase, particularly targeting neuronal NOS (NOS1). This agent has not been approved for clinical use and remains at the experimental stage[1][3][6].

Other names

L-N(OMEGA)-NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE(2S)-2-amino-N-((1S)-3-amino-1-carbamoylpropyl)-5-(N'-nitrocarbamimidamido)pentanamide(2S)-2-amino-N-[(1S)-3-amino-1-carbamoylpropyl]-5-(N'-nitrocarbamimidamido)pentanamide